Success Stories: Fighting Blood Cancer with Precision: Assistant Professor in Clinical Immunotherapy Medicine Granted NIW with Strategic Help from NAILG
Client’s Testimonial:
“I am sincerely grateful to NAILG for their expert guidance and strategic support throughout my NIW petition process. Their team demonstrated a strong understanding of my work and presented it effectively to meet USCIS standards. The petition was ultimately approved in just over a month with premium processing. While communication was highly responsive and thorough during most of the process, I did notice some delays toward the final stages. Nonetheless, I appreciate their dedication and would recommend NAILG to others pursuing an NIW.”
On May 13th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Hospitalist/Clinical Assistant Professor in the Field of Clinical Immunotherapy Medicine (Approval Notice).
General Field: Clinical Immunotherapy Medicine
Position at the Time of Case Filing: Hospitalist/Clinical Assistant Professor
Country of Origin: China
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: May 13th, 2025
Processing Time: 1 month, 10 days (Premium Processing Requested)
Case Summary:
An assistant professor stands at the forefront of clinical immunotherapy, merging laboratory innovation with patient-centered treatment for blood cancers. His proposed endeavor focuses on enhancing CAR-T cell therapy for hematological malignancies by integrating high-impact research with compassionate, trial-based care. His goal is to close the translational gap - bringing discoveries out of the lab and into the hands of clinicians, where they can improve lives.
As an expert in personalized medicine and immune cell engineering, our client plays a vital role in reshaping the clinical approach to leukemia and other blood cancers. His research supports the development of therapies that are not only effective but also accessible, offering hope to patients through more precise and responsive interventions. As one expert recommendation stated:
“In conclusion, [client]'s skillset and contributions to the field are irreplaceable, given the immense benefits of her acute myeloid leukemia to healthcare treatment availabilities in the United States and beyond. It is essential that he be allowed to carry out his research without interruption so that the United States can fully benefit from its value.”
Academic Contributions and Recognition➢ 9 peer-reviewed journal articles, including 3 first- or co-first-authored, 2 abstracts
➢ 1 granted patent
➢ 39 total citations
➢ At least 25 completed peer reviews
➢ Research funded by the National Natural Science Foundation of China (NSFC)
Seamless Legal Strategy with NAILGTo advance his groundbreaking work in the United States, our client partnered with the North America Immigration Law Group (NAILG) to file his National Interest Waiver (NIW) petition. Drawing on deep expertise in immigration law for researchers and clinicians, NAILG crafted a customized legal strategy that emphasized his unique qualifications, real-world clinical impact, and contributions to public health. By aligning his achievements with national priorities in cancer treatment and biomedical innovation, NAILG presented a compelling case that led to swift NIW approval, clearly affirming his value to the U.S. medical research ecosystem.